Results 221 to 230 of about 101,816 (333)

Safety of sulfamethoxazole–trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta‐analysis with active comparator disproportionality analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Sulfamethoxazole–trimethoprim (SMX‐TMP) is a widely used antibiotic for treating bacterial infections, but its safety in adult outpatients remains understudied. This systematic review and meta‐analysis evaluated the safety profile of SMX‐TMP and identified critical research gaps.
Rebecca Preyra, Lujain Ez Eddin, Fatemeh Ahmadi, Atefeh Jafari, Flory T. Muanda   +4 more
wiley   +1 more source

The role of CsrA in controls the extracellular electron transfer and biofilm production in <i>Geobacter sulfurreducens</i>. [PDF]

Front Microbiol
Hernández-Eligio A, Vega-Alvarado L, Liu X, Cholula-Calixto J, Huerta-Miranda G, Juárez K.   +5 more
europepmc   +1 more source

Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the effect of a potent cytochrome P450 (CYP) 3A inhibitor and CYP inducer on the pharmacokinetics of ritlecitinib, a JAK3/TEC family kinase inhibitor, and assess the effect of ritlecitinib on the pharmacokinetics of CYP substrates (midazolam, efavirenz, tolbutamide, caffeine and oral contraceptives [ethinyl oestradiol and levonorgestrel])
Vivek S. Purohit, Yeamin Huh, Martin E. Dowty, Anna Plotka, Alexandre Lejeune, Hindu Kalluru, Brian Hee   +6 more
wiley   +1 more source

Flavonoids and Furanocoumarins Involved in Drug Interactions. [PDF]

Molecules
Berteina-Raboin S.
europepmc   +1 more source

A Bacterial Diphosphopyridine Nucleotide-Linked Cytochrome c Reductase

, 1952
Arnold F. Brodie
openalex   +1 more source

Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations

British Journal of Clinical Pharmacology, EarlyView.
Aims Voriconazole is extensively metabolized via cytochrome P450 (CYP) enzymes, predominantly CYP2C19 and CYP3A4. Drugs influencing the activity or expression of CYP enzymes can cause clinically relevant changes in the metabolism and voriconazole exposure. Metamizole is known to induce CYP3A4 and CYP2C19.
Simone D. Baan, Daan J. Touw, Marjolijn N. Lub‐de Hooge, Thijs H. Oude Munnink   +3 more
wiley   +1 more source

Anaerobic corrosion of steel wire by <i>Geoalkalibacter ferrihydriticus</i> under alkaline autotrophic conditions. [PDF]

Appl Environ Microbiol
Zavarzina DG, Chistyakova NI, Kohout J, Merkel AY, Perevalova AA, Kubaniova D, Chernov MS, Frolov EN, Klyuev AL, Gavrilov SN.   +9 more
europepmc   +1 more source

COLORIMETRIC MICRODETERMINATION OF CYTOCHROME c OXIDASE

, 1954
Werner Straus
openalex   +1 more source

Pharmacology and relevant drug interactions of metamizole

British Journal of Clinical Pharmacology, EarlyView.
Metamizole is a frequently prescribed analgesic because of its favourable benefit/risk ratio compared with classic NSAIDs. However, increasing research shows that metamizole displays several drug interactions that are relevant to clinical practice. We reviewed the literature to summarize the pharmacology and most clinically relevant drug interactions ...
David J. Brinkman, Linda C. Hendriksen, Irma M. Rigter, Markus W. Hollmann   +3 more
wiley   +1 more source

Raman microscopy of cryofixed biological specimens for high-resolution and high-sensitivity chemical imaging. [PDF]

Sci Adv
Mizushima K, Kumamoto Y, Tamura S, Yamanaka M, Mochizuki K, Li M, Egoshi S, Dodo K, Harada Y, Smith NI, Sodeoka M, Tanaka H, Fujita K.   +12 more
europepmc   +1 more source